Escherichia Coli Strain Market
According to Intent Market Research, the Escherichia Coli Strain Market is expected to grow from USD 1.7 billion in 2023 at a CAGR of 6.5% to touch USD 2.6 billion by 2030. The Escherichia Coli Strain Market is dominated by key players such as Thermo Fisher Scientific, Becton, Dickinson and Company (BD), Merck & Co., Inc., AbbVie Inc., Danaher Corporation, Bayer AG, Lonza Group, Agilent Technologies, Sigma-Aldrich Corporation, Jena Bioscience, F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Eppendorf AG, GenScript Biotech Corporation, New England Biolabs